Edition:
United States

Achillion Pharmaceuticals Inc (ACHN.OQ)

ACHN.OQ on NASDAQ Stock Exchange Global Select Market

2.38USD
15 Feb 2019
Change (% chg)

$0.03 (+1.28%)
Prev Close
$2.35
Open
$2.35
Day's High
$2.43
Day's Low
$2.34
Volume
441,470
Avg. Vol
415,995
52-wk High
$4.34
52-wk Low
$1.29

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Sep '18 0.00 -0.115
Jun '18 0.00 -0.124
Mar '18 0.00 -0.149
FY 2017 Dec '17 0.00 -0.168
Sep '17 0.00 -0.141
Jun '17 0.00 -0.165
Mar '17 0.00 -0.147
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Mar-19 3 0.00 0.00 0.00 --
Quarter Ending Jun-19 3 0.00 0.00 0.00 --
Year Ending Dec-19 4 0.00 0.00 0.00 0.00
Earnings (per share)
Quarter Ending Mar-19 3 -0.16 -0.15 -0.16 -0.25
Quarter Ending Jun-19 3 -0.17 -0.16 -0.18 -0.25
Year Ending Dec-19 4 -0.68 -0.60 -0.73 -0.84
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 88.11 35.99
P/E High - Last 5 Yrs. -- 132.66 51.07
P/E Low - Last 5 Yrs. -- 50.39 25.99
Beta 2.42 1.06 0.95
Price to Sales (TTM) -- 53.40 10.11
Price to Book (MRQ) 1.18 12.55 4.60
Price to Tangible Book (MRQ) 1.18 17.25 5.67
Price to Cash Flow (TTM) -- 62.05 26.60
% Owned Institutions -- 0.00 0.00

Dividends

  Company industry sector
Dividend Yield -- 0.10 1.59
Dividend Yield - 5 Year Avg -- 0.05 1.37
Dividend 5 Year Growth Rate -- 0.75 -7.66
Payout Ratio(TTM) -- 9.58 57.91

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 48.64 13.97
Sales (TTM) vs TTM 1 Yr. Ago -100.00 26.88 5.68
Sales - 5 Yr. Growth Rate -- 23.40 8.76
EPS (MRQ) vs Qtr. 1 Yr. Ago 18.58 8.83 1.73
EPS (TTM) vs TTM 1 Yr. Ago -14.61 -- --
EPS - 5 Yr. Growth Rate -- 19.09 8.38
Capital Spending - 5 Yr. Growth Rate -0.93 11.42 9.37

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.69 2.54
Current Ratio (MRQ) 33.21 3.52 3.50
LT Debt to Equity (MRQ) 0.00 15.82 13.45
Total Debt to Equity (MRQ) 0.06 29.82 16.95
Interest Coverage (TTM) -- 14.67 40.10

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 56.45 51.00
Gross Margin - 5 Yr. Avg. -- 63.45 52.41
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -363.39 4.31 17.39
Operating Margin (TTM) -- -284.48 -6.46
Operating Margin - 5 Yr. Avg. -367.90 -12.07 12.33
Pre-Tax Margin (TTM) -- -274.71 -5.56
Pre-Tax Margin - 5 Yr. Avg. -345.07 -16.01 12.48
Net Profit Margin (TTM) -- -281.73 -9.13
Net Profit Margin - 5 Yr. Avg. -345.07 -21.54 8.76
Effective Tax Rate (TTM) -- 21.70 22.24
Effective Tax Rate - 5 Yr. Avg. -- 18.55 23.52

Efficiency

  Company industry sector
Revenue/Employee (TTM) 0 7,090,849 793,051,265
Net Income/Employee (TTM) -873,568 1,473,290 92,015,479
Receivable Turnover (TTM) -- 3.07 4.90
Inventory Turnover (TTM) -- 1.92 3.67
Asset Turnover (TTM) 0.00 0.33 0.85

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -23.67 8.02 10.19
Return on Assets - 5 Yr. Avg. -19.89 6.60 11.12
Return on Investment (TTM) -24.54 10.12 12.72
Return on Investment - 5 Yr. Avg. -20.81 8.66 14.32
Return on Equity (TTM) -24.55 10.40 13.73
Return on Equity - 5 Yr. Avg. -20.83 9.06 15.40
  1 Year 3 Year 5 Year
Sales % -100.00 -- --
EPS (TTM) % -37.61 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Achillion Pharmaceuticals Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 8.68 4.57 99 74
13 Week -17.36 -18.53 58 26
26 Week -5.93 -3.40 99 9
52 Week -22.48 -23.72 99 6
YTD 49.69 35.19 99 9
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 79.35%
# of Holders: 178
Total Shares Held: 109,994,869
3 Mo. Net Change: -3,545,704
# New Positions: 14
# Closed Positions: 27
# Increased Positions: 65
# Reduced Positions: 77
# Net Buyers: -12
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.